1. Home
  2. PRAX vs SBSW Comparison

PRAX vs SBSW Comparison

Compare PRAX & SBSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$322.54

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo D/B/A Sibanye-Stillwater Limited ADS

SBSW

D/B/A Sibanye-Stillwater Limited ADS

HOLD

Current Price

$8.60

Market Cap

5.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
SBSW
Founded
2015
2013
Country
United States
South Africa
Employees
N/A
72668
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
5.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PRAX
SBSW
Price
$322.54
$8.60
Analyst Decision
Strong Buy
Buy
Analyst Count
15
3
Target Price
$572.13
$19.93
AVG Volume (30 Days)
548.0K
5.5M
Earning Date
05-08-2026
02-20-2026
Dividend Yield
N/A
2.17%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$43.55
Revenue Next Year
$7,758.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.25
$7.10
52 Week High
$366.52
$21.29

Technical Indicators

Market Signals
Indicator
PRAX
SBSW
Relative Strength Index (RSI) 54.07 37.88
Support Level $282.49 N/A
Resistance Level $344.07 $11.25
Average True Range (ATR) 21.29 0.31
MACD 2.92 0.06
Stochastic Oscillator 54.65 40.21

Price Performance

Historical Comparison
PRAX
SBSW

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other. Group operations are divided into two segments, South African Operations and International and recycling operations.

Share on Social Networks: